{ "model": "qwen/qwen3.6-35b-a3b", "started_at": "2026-05-14T22:35:50.922Z", "system_prompt": "You are Analyst, the thesis-judgment stage of an AI trade-ideas pipeline.\n\nScout has already gathered a JSON dossier of scoring_inputs. Your job is to\nSCORE the dossier against the methodology rubric and either draft an idea\n(if score ≥ 60) or skip.\n\nOPTION B (skip) IS THE EXPECTED DEFAULT. The pipeline publishes rarely and\nonly when something clears a high bar. Most dossiers should return\n{ \"skip\": true, \"reason\": \"...\", \"score\": }. Mediocre publishes burn\nDevil's Advocate budget and create credibility risk on the public site.\n\nLOOK AT THE FULL STRUCTURE MENU. Even when Scout says 'no asymmetric long\nopportunity exists' (verdict=range_bound_or_income), there may be a clear\nINCOME structure (covered call against the high; strangle inside an IV-\nelevated band; CSP at a downside-defended strike). Don't reflex-skip just\nbecause long_stock isn't attractive. Read the dossier looking for what\nSHAPE OF TRADE fits, not just whether long is fits.\n\nSCORING RUBRIC (sum to max 100)\n\nA. SMART-MONEY CLUSTER (max 25) — from scoring_inputs.smart_money\n • 10 pts if 3+ distinct insiders with open-market purchases (code P) in\n last 90 days totaling ≥ $500K\n • +3 pts if CEO is among the buyers\n • +3 pts if CFO is among the buyers\n • +2 pts if total purchases > $5M\n • 5 pts for a known concentrated 13F initiation/add (Berkshire, Pershing\n Square, Appaloosa, Greenlight, Scion, Polen, Pabrai, Tepper, etc.)\n • +3 pts if it's in the manager's top-3 positions\n • 2 pts for politician STOCK Act recent buy\n • +1 pt if multiple unrelated members bought within 30 days\n • Penalty: −10 pts if material insider SELLING > BUYING in dollars\n\nB. OPTIONS FLOW / UOA (max 10) — from scoring_inputs.options_flow\n • 4 pts: whale_call_blocks_otm ≥ 2 with flow_directional_bias = bullish\n and flow_strength ∈ {moderate, strong}\n • 3 pts: bullish IV skew (call IV > put IV) consistent with thesis\n • 2 pts: net_dollar_bias_pct > 30 (sustained call-side flow)\n • 1 pt: large OI building at a defended price level\n • Penalty: −5 pts if whale_put_blocks_otm ≥ 2 and bias is bearish\n without a hedging explanation\n\nC. CATALYST (max 25) — from scoring_inputs.catalyst\n • 10 pts: earnings within 90 days AND last 4 quarters' EPS surprise > 0%\n • 8 pts: pending product launch / FDA / contract milestone in horizon\n • 5 pts: recent guidance raise (last 90 days)\n • 5 pts: quantifiable sector tailwind (named hyperscaler capex flowing\n to this name in $)\n Cap at 25 even if components add to more.\n\nD. MISPRICING (max 15) — from scoring_inputs.mispricing\n • 5 pts: forward P/E ≥ 20% below sector median (with non-deteriorating\n earnings)\n • 4 pts: EV/EBITDA ≥ 30% below sector median\n • 4 pts: FCF yield ≥ 7% with stable FCF\n • 5 pts: SOTP gap ≥ 25% (replaces one of the above)\n Cap at 15.\n\nE. QUALITY (max 15) — from scoring_inputs.quality\n • 5 pts: ROIC ≥ 15% (or trending there)\n • 5 pts: gross margin expanding ≥ 3pp YoY\n • 5 pts: net debt / EBITDA ≤ 2x (or net cash)\n\nF. MOMENTUM/TECHNICAL (max 10) — from scoring_inputs.technical\n • 3 pts: above both 50DMA and 200DMA\n • 4 pts: 12-1 month price return positive AND beating sector\n • 2 pts: RSI 14 in 40-65 zone\n • 1 pt: MACD bullish cross in last 30 days\n\nRISK CLASS — choose one based on the dossier's market_cap field:\n \"core\" — market_cap > $5B. Standard methodology sizing.\n \"asymmetric\" — market_cap ≤ $5B (small-cap moonshot). 90%+ of these\n bets lose money or go to zero; the few that work pay\n for the rest. Position sizing is far more conservative\n to fit the variance.\n\nTHRESHOLDS — depend on risk_class\n\n CORE risk_class:\n ≥ 80 Publish, confidence 5, position size cap 4-5%\n 70-79 Publish, confidence 4, position size cap 2.5-3.0%\n 60-69 Publish, confidence 3, position size cap 1.5-2.0%\n 50-59 Skip unless catalyst <30d + insider cluster\n < 50 Skip\n\n ASYMMETRIC risk_class — strict sizing:\n ≥ 80 Publish, confidence 5, position size cap 1.5%\n 70-79 Publish, confidence 4, position size cap 1.0%\n 60-69 Publish, confidence 3, position size cap 0.5%\n < 60 Skip (no exception; small caps need a clear catalyst)\n Structure must be long_stock (options structures are wrong shape for\n moonshots; Compliance enforces this in code).\n\nANTI-SIGNAL GATES (any one of these forces skip regardless of score):\n • Going-concern audit qualification\n • Pending material litigation (DOJ/SEC enforcement, class action with merit)\n • Customer concentration > 30%\n • Convertible/warrant overhang creating dilution > 10% of float\n • Accounting irregularities (restatements, auditor changes)\n • Avg daily volume < $5M (liquidity gate)\n • Pump-and-dump signals (sudden volume + chat-room mentions)\n\nIf scoring_inputs has anti_signals_present non-empty, treat each entry as a\ngate; skip unless you can articulate WHY it doesn't apply to this case.\n\nEDGE CHECK (philosophical, not numeric)\n\nAfter scoring, ask: \"What does this idea say that the market doesn't already\nknow?\" If the answer is generic (it's cheap, AI is a tailwind, technicals\nlook great), the score is misleading — skip even if numerical score is 65.\nReal edge means a specific data point or interpretation the market missed.\n\nSCOUT VERDICT → STRUCTURE GUIDANCE\n\nRead scoring_inputs and Scout's verdict together. The verdict tells you\nWHICH structures Scout thinks are in scope for this name:\n\n verdict='promising' → long_stock | csp (for asymmetric long)\n verdict='range_bound_or_income' → cc | strangle | csp on pullback\n (DON'T default to long_stock — Scout\n already said this isn't an asymmetric\n long. Look at IV elevated → strangle;\n stock at 52w high, fundamentals healthy\n → cc against implicit long; pullback\n thesis with cash → csp)\n verdict='bearish_setup' → naked_call (rarely; respect ceiling)\n\nIf Scout supplied structure_hints[], they're a starting point. You can\noverride with reasoning, but if you go OUTSIDE the verdict's natural set,\nexplain why in thesis_long.\n\nSTRUCTURE SELECTION — full menu:\n\n long_stock — multi-quarter asymmetric thesis, IV not elevated, want\n full upside participation\n csp — bullish, want to own at strike, IV elevated, ann yield ≥15%\n cc — range-bound or mildly bullish, IV elevated, on top of long\n stock leg, if-called return ≥15% ann\n strangle — RANGE-BOUND thesis with elevated IV. Sell OTM call + OTM\n put. Need: comfortable owning at put_strike, no parabolic\n upside expectation. Ann yield ≥12%. Compute and emit\n breakeven_high (call_strike + total_premium) and\n breakeven_low (put_strike - total_premium).\n naked_put — same setup as CSP but using margin. ~2x yield, margin call\n risk. Only for margin-equipped accounts. Note explicitly.\n naked_call — bearish setup with elevated IV. UNCAPPED loss if rally.\n Confidence ceiling 4 (Compliance enforces). Requires\n explicit upside-shock thesis + defense plan in conditions.\n\nMatch the structure to the thesis shape — don't reach for naked options\njust because the premium is fatter. Most candidates are best as long_stock\nor CSP. Strangles only when you have a clear range thesis backed by IV\nand fundamentals.\n\nIF YOU SKIP — output exactly:\n {\n \"skip\": true,\n \"score\": <0-100 composite>,\n \"score_breakdown\": {\n \"smart_money\": <0-25>, \"options_flow\": <0-10>, \"catalyst\": <0-25>,\n \"mispricing\": <0-15>, \"quality\": <0-15>, \"technical\": <0-10>\n },\n \"reason\": \"1-2 sentences why this dossier doesn't support a thesis.\"\n }\n\nIF YOU PROCEED — output a draft idea matching this schema (this is the same\nschema the published site renders from):\n\n{\n \"skip\": false,\n \"score\": <0-100 composite>,\n \"score_breakdown\": {\n \"smart_money\": <0-25>, \"options_flow\": <0-10>, \"catalyst\": <0-25>,\n \"mispricing\": <0-15>, \"quality\": <0-15>, \"technical\": <0-10>\n },\n \"draft\": {\n \"slug\": \"YYYY-MM-DD-symbol-keyphrase\",\n \"symbol\": \"TICKER\",\n \"company\": \"Full name\",\n \"sector\": \"semis-ai-infra\" | \"small-cap-asymmetric\",\n \"risk_class\": \"core\" | \"asymmetric\",\n \"headline\": \"Punchy 1-line — the news angle on the thesis\",\n \"thesis_short\": \"1 sentence — why this trade exists.\",\n \"thesis_long\": [\n \"Opening paragraph framing the setup.\",\n \"## Catalyst\",\n \"Detailed catalyst narrative.\",\n \"## Why the market is mispricing this\",\n \"Edge explanation, citing dossier facts.\",\n \"## Numbers\",\n \"- Bullet 1 with concrete numbers from the dossier\",\n \"- Bullet 2\",\n \"## Risk\",\n \"Honest description of what could go wrong.\"\n ],\n \"structure\": {\n \"type\": \"long_stock\" | \"csp\" | \"cc\" | \"strangle\" | \"naked_put\" | \"naked_call\",\n \"long_stock\": { \"entry_zone_low\": , \"entry_zone_high\": , \"shares_per_unit\": 100 },\n \"csp\": { \"strike\": , \"expiry\": \"YYYY-MM-DD\", \"premium_target\": , \"annualized_yield_pct\": , \"if_assigned_basis\": },\n \"cc\": { \"underlying_basis\": , \"strike\": , \"expiry\": \"YYYY-MM-DD\", \"premium_target\": , \"if_called_return_pct\": },\n \"strangle\": { \"call_strike\": , \"put_strike\": , \"expiry\": \"YYYY-MM-DD\", \"call_premium_target\": , \"put_premium_target\": , \"total_premium_target\": , \"breakeven_high\": , \"breakeven_low\": , \"annualized_yield_pct\": , \"max_loss_note\": \"...\" },\n \"naked_put\": { \"strike\": , \"expiry\": \"YYYY-MM-DD\", \"premium_target\": , \"annualized_yield_pct\": , \"max_loss_per_contract\": , \"margin_estimate_per_contract\": , \"warning\": \"...\" },\n \"naked_call\": { \"strike\": , \"expiry\": \"YYYY-MM-DD\", \"premium_target\": , \"annualized_yield_pct\": , \"max_loss\": \"UNLIMITED\", \"warning\": \"...\" }\n },\n \"entry\": {\n \"price_at_idea\": ,\n \"conditions\": \"How/when to enter — e.g., 'Open starter on pullback to MA50.'\"\n },\n \"exit\": {\n \"target_price\": ,\n \"time_horizon_months\": ,\n \"stop_conditions\": \"Specific signal(s) that trigger a close.\"\n },\n \"risk\": {\n \"bear_case\": \"Honest, specific bear case (not generic 'market could fall').\",\n \"what_breaks_thesis\": \"Specific event/data that invalidates the call.\",\n \"position_size_pct\": <0.5 to 5.0, conviction-weighted>\n },\n \"sources\": [\n { \"label\": \"...\", \"url\": \"...\" }\n ],\n \"confidence\": <1-5, conservative>,\n \"analyst\": \"research-desk\",\n \"scout_model\": \"minimax/minimax-m2.7\",\n \"analyst_model\": \"qwen/qwen3.6-35b-a3b\",\n \"devils_advocate_verdict\": null\n }\n}\n\nONLY ONE STRUCTURE TYPE. Pick long_stock, csp, OR cc and only fill that\nsub-object. Leave the others null/omitted.\n\nALL NUMBERS must be drawn from the dossier or computable from it. Do not\ninvent prices, strikes, premiums.\n\nOUTPUT ONLY VALID JSON. No surrounding prose, no markdown fences.", "user_prompt": "Here is the dossier from Scout. Decide: skip or draft.\n\n\nLESSONS LEARNED: none yet.\n\nDOSSIER:\n{\n \"symbol\": \"MCHP\",\n \"company\": \"Microchip Technology Incorporated\",\n \"investigation_summary\": \"Microchip is in operational recovery mode after 18 months of inventory correction — Q4 FY2026 beat consensus by +13% and forward guidance was +8.3% above estimates with double-digit growth projected for Q1 FY2027. However, the stock has already surged ~53% YTD off the November 2025 lows ($49) to near 52-week highs ($105). No insider open-market purchases were found — CEO Sanghi executed large sales through 10b5-1 plans at $88-$93 in April-May. The most notable options signal is a massive ITM call block on June 18 (89,775 contracts at $55 strike = ~$388M notional), which is deeply out-of-the-money relative to the current $97 spot and likely represents an LEAP conversion collar or ratio structure rather than a directional bet. Forward P/E of 23.7x sits slightly above sector medians; EV/EBITDA of ~46x is notably rich vs. TI at ~32x. The balance sheet shows net debt of $5.37B, and the company just issued an $900M zero-coupon convertible in Feb-2026 with a capped call at $148.82 — management hedges dilution up to that level, consistent with confidence but not an asymmetric setup at current prices.\",\n \"verdict\": \"range_bound_or_income\",\n \"confidence_in_data\": 4,\n \"structure_hints\": [\n \"cc\",\n \"strangle\"\n ],\n \"business_snapshot\": \"Microchip Technology is a ~$52B market cap semiconductor company (Nasdaq: MCHP) specializing in 8/16/32-bit microcontrollers, analog products, and timing solutions serving industrial, automotive, data center, communications, and consumer end markets. The company generates ~60% gross margins on its core Semiconductor Products segment with Technology Licensing contributing the remainder. FY2025 revenue was approximately $4.7B; Q3 FY2026 (Dec-2025 quarter) delivered $1.186B (+15.6% YoY) with non-GAAP EPS of $0.57 beating consensus by +12.9%. Inventory destocking that compressed results for 18 months has normalized and the company is now in a broad demand recovery phase. Key product expansions include timing (EX-423 EMXO crystal oscillator May-2026), MRAM manufacturing partnership (Everspin agreement Apr-2026), and new microcontroller families targeting AI edge inference. The capital structure carries $5.37B net debt plus ~$1.485B in Series A Mandatory Convertible Preferred Stock, though the Feb-2026 issuance of a 0% convertible due 2030 ($900M face) with capped call at $148.82 provides financial flexibility.\\n\\nFinancial performance has inflected sharply upward: Q4 FY2025 EPS $0.27 (+13% beat), Q1 FY2026 EPS $0.35 (+5%), Q2 FY2026 EPS $0.44 (+3%), Q3 FY2026 EPS $0.57 (+13%). The most recent quarter showed revenue up ~15% YoY with bookings surge and distributor inventory normalization — a pattern suggesting the recovery has breadth across end markets rather than concentration in one vertical.\\n\\nThe balance sheet is under leverage pressure: $250M cash vs. $5.37B long-term debt creates meaningful interest expense (~$170M semi-annually) that suppresses net income even as revenue recovers. FCF conversion is improving with inventory reduction releasing ~$240M in Q3 alone, and the company returned $737M to common shareholders via dividends over nine months.\",\n \"scoring_inputs\": {\n \"smart_money\": {\n \"insider_open_market_purchases_90d\": [],\n \"insider_open_market_total_usd_90d\": 0,\n \"distinct_insider_buyers_90d\": 0,\n \"ceo_buy_present\": false,\n \"cfo_buy_present\": false,\n \"material_insider_selling_90d_usd\": 96000000,\n \"notable_13f_holders\": [\n \"pending — v2\"\n ],\n \"politician_recent_buys\": [\n \"pending — v2\"\n ]\n },\n \"catalyst\": {\n \"next_earnings_date\": \"2026-08-06\",\n \"recent_eps_surprise_pattern\": \"4 consecutive quarterly beats: Q4 FY2025 +13.17%, Q1 FY2026 +4.93%, Q2 FY2026 +2.75%, Q3 FY2026 +12.93%. Most recent quarter (Q4 FY2026, reported May-7-2026) showed strong beat with revenue guidance for Q1 FY2027 $1.46B midpoint vs consensus ~$1.35B (+8.3% above).\",\n \"guidance_raise_in_last_90d\": true,\n \"named_catalysts\": [\n {\n \"type\": \"earnings\",\n \"description\": \"Q4 FY2026 beat (May-7-2026): non-GAAP EPS $0.57, +12.9% vs estimate; revenue guidance Q1 FY2027 at midpoint $1.46B (+8.3% above consensus). Booking surge cited as evidence of sustained demand recovery.\",\n \"date_or_window\": \"2026-05-07\",\n \"source_urls\": [\n \"https://www.sec.gov/Archives/edgar/data/827054/000082705426000012/mchp-20260507.htm\"\n ],\n \"directional_bias\": \"bullish\"\n },\n {\n \"type\": \"product\",\n \"description\": \"EX-423 Evacuated Miniature Crystal Oscillator (EMXO) launch — extends timing portfolio into mission-critical applications; MRAM manufacturing agreement with Everspin (10-year strategic partnership for US production).\",\n \"date_or_window\": \"2026-05-14 / 2026-04-08\",\n \"source_urls\": [\n \"https://finance.yahoo.com/sectors/technology/articles/ex-423-evacuated-miniature-crystal-120000854.html\"\n ],\n \"directional_bias\": \"bullish\"\n },\n {\n \"type\": \"sector\",\n \"description\": \"Broad semiconductor recovery: inventory normalization complete, AI/data center demand growing for Microchip's timing and MCU products. Morgan Stanley raised sector price targets in May 2026.\",\n \"date_or_window\": \"Ongoing through 2026\",\n \"source_urls\": [\n \"https://www.thestreet.com/investing/stocks/morgan-stanley-raises-price-targets-across-semiconductor-sector\"\n ],\n \"directional_bias\": \"bullish\"\n }\n ]\n },\n \"mispricing\": {\n \"forward_pe\": 23.72,\n \"sector_median_forward_pe\": 22,\n \"ev_to_ebitda\": 46.5,\n \"sector_median_ev_to_ebitda\": 33,\n \"fcf_yield_pct\": 2.1,\n \"sotp_gap_pct\": null,\n \"narrative\": \"Forward P/E of ~23.7x is at a modest premium to the semi sector median (~22x) given ongoing recovery trajectory — not obviously cheap, but not wildly expensive either on 2026 estimates. The more concerning metric is EV/EBITDA: 46x vs peers at 30-35x reflects accumulated goodwill/intangibles from acquisitions and leverage in capital structure, making MCHP the most expensive name by this metric among mature analog/semi peers.\"\n },\n \"quality\": {\n \"roic_pct\": 3.4,\n \"gross_margin_trend_pp_yoy\": \"Q3 FY2026 gross margin ~59.6% vs prior year comparable quarter ~54.7% = +490bps YoY improvement, driven by favorable product mix and operating leverage\",\n \"net_debt_to_ebitda\": 5,\n \"balance_sheet_grade\": \"C\"\n },\n \"technical\": {\n \"above_50dma\": true,\n \"above_200dma\": null,\n \"rsi_14\": 67.2,\n \"macd_recent_bullish_cross\": false,\n \"12_1_momentum_vs_sector_pct\": 8\n },\n \"price_context\": {\n \"last_close\": 97.04,\n \"ytd_return_pct\": 53.77,\n \"from_52w_high_pct\": 8.4\n },\n \"filings_reviewed\": [\n {\n \"form\": \"10-K\",\n \"filed\": \"2025-05-23\",\n \"url\": \"https://www.sec.gov/Archives/edgar/data/827054/000082705425000077/mchp-20250331.htm\",\n \"key_takeaways\": [\n \"FY2025 (Mar year-end) revenue $4.7B, +35% YoY; gross margin 57.7%; net debt $5.37B vs cash $240M; significant goodwill ($6.7B) and intangible assets ($2.1B net); customer concentration: Arrow Electronics is a major distributor; geographic: ~43% international revenue including Thailand manufacturing exposure\"\n ]\n },\n {\n \"form\": \"10-Q\",\n \"filed\": \"2026-02-05\",\n \"url\": \"https://www.sec.gov/Archives/edgar/data/827054/000082705426000009/mchp-20251231.htm\",\n \"key_takeaways\": [\n \"Q3 FY2026 (Dec quarter): Revenue $1.186B (+15.6% YoY), gross profit $706.9M (59.6% margin), operating income $151.7M; inventory reduced to $1.058B from $1.294B a year ago = ~$240M cash release; long-term debt $5.37B; 0% convertible notes due Feb-2030 issued ($900M face, conversion price $104.17); Series A Mandatory Convertible Preferred Stock outstanding ($1.485B aggregate liquidation preference)\"\n ]\n },\n {\n \"form\": \"8-K\",\n \"filed\": \"2026-02-11\",\n \"url\": \"https://www.sec.gov/Archives/edgar/data/827054/000119312526046713/d18435d8k.htm\",\n \"key_takeaways\": [\n \"$800M + $100M greenshoe convertible senior notes at 0% coupon, due Feb-15-2030; conversion rate: 9.5993 shares per $1,000 principal (conversion price ~$104.17); capped call transactions with strike at ~$148.82; net proceeds $883M used partly for commercial paper repayment and capped calls\"\n ]\n },\n {\n \"form\": \"8-K\",\n \"filed\": \"2026-05-07\",\n \"url\": \"https://www.sec.gov/Archives/edgar/data/827054/000082705426000012/mchp-20260507.htm\",\n \"key_takeaways\": [\n \"Q4 FY2026 earnings beat; Q1 FY2027 revenue guidance $1.46B midpoint vs ~$1.35B consensus (+8.3% above); bookings surge and inventory normalization cited as demand recovery evidence\"\n ]\n }\n ],\n \"options_context\": {\n \"expiries_examined\": [\n \"2026-06-18\",\n \"2026-05-15\",\n \"2026-05-22\",\n \"2026-06-12\",\n \"2026-09-18\"\n ],\n \"iv_summary\": \"ATM IV on the Jun-18 expiry is ~50.8% (mid-point of $97.5 call at 0.507 and put). The deep ITM $55 call block carries IV of 102%, suggesting it's a synthetic position rather than a standalone directional trade.\",\n \"notable_skew_or_flow\": \"The dominant signal is the massive $388M notional ITM call block on Jun-18 $55 strike (89,775 contracts at ~$4.33/sh). This represents deep-in-the-money calls on an expiry 34 DTE from now — given spot is $97 and strike is $55, this is equivalent to owning stock with a cost basis of $59.33 per share (= strike + call premium). This looks like a LEAP-equivalent conversion or long-stock substitution position rather than a directional OTM bet. V/OI ratio of 1.99 confirms new positioning. The whale call on the 17.5 strike ($259K notional) is noise (only 43 contracts vs zero prior OI). The ITM $55 block dominates and suggests someone is positioned for MCHP above ~$100-$105 at June expiry.\"\n },\n \"competitive_landscape\": \"Microchip competes with Texas Instruments (TXN), NXP Semiconductors (NXPI), Renesas, and STMicroelectronics (STM) in microcontrollers; Analog Devices (ADI) and TI in analog. At EV/EBITDA 46x vs TXN ~32-35x, MCHP is the most expensive name in its peer set by this metric — a premium that requires flawless execution on the inventory recovery thesis to sustain. The company's differentiated positioning in 8-bit MCUs (historically high-margin niche) and timing products provides some protection from pure commoditization pressure. Management cited AI/data center demand as emerging growth driver — a newer narrative vs competitors who already have established AI-related revenue.\",\n \"key_risks\": [\n \"Leverage risk: $5.37B net debt with only $250M cash creates vulnerability to semiconductor cycle downturns; interest expense ~$340M annually compresses EPS recovery\",\n \"Insider selling via 10b5-1: CEO Sanghi sold $96M+ in April-May through pre-planned programs at $88-$93 — not a buy signal, though his remaining stake of ~9.4M shares is substantial\",\n \"Valuation premium vs peers on EV/EBITDA (46x vs TXN 32x) means limited upside if execution slips; any demand weakness will cause multiple contraction\",\n \"Convertible dilution: existing convertibles (2017 Senior at $2B, 2024 Senior) + new Feb-2026 0% convertible ($900M face value) represent ~$3.9B potential share issuance; capped call provides partial hedge but dilutes if stock exceeds cap prices\",\n \"Inventory reloading risk: distributor inventory normalization drove recent recovery — if distributors reload too aggressively it could create another overhang in Q2-Q3 FY2027\",\n \"Tariff/exchange rate exposure: significant Thailand manufacturing presence (noted in 10-K); currency and geopolitical risks on international revenue (~43% of sales)\"\n ],\n \"what_the_market_might_be_missing\": \"The Everspin MRAM partnership (announced April-8-2026) represents a long-duration bet on U.S.-based next-generation memory that could position MCHP in the AI inference supply chain — but this is too early-stage to be a near-term re-rating catalyst. The more concrete mispricing angle: market may not fully appreciate the magnitude of inventory normalization tail-wind and how much Q4 bookings represent durable demand vs distributor restocking that could reverse quickly. Conversely, what bulls point to is 18 months of channel inventory clearance now complete — with lead times shortening and distributors reporting normalized levels for first time since early FY2024, MCHP may have genuine operating leverage ahead as revenue recovers without proportional cost growth.\",\n \"anti_signals_present\": [\n \"dilution\",\n \"concentration\"\n ],\n \"sources\": [\n {\n \"label\": \"Q4/FY2026 earnings release (8-K)\",\n \"url\": \"https://www.sec.gov/Archives/edgar/data/827054/000082705426000012/mchp-20260507.htm\"\n },\n {\n \"label\": \"Q3 FY2026 10-Q\",\n \"url\": \"https://www.sec.gov/Archives/edgar/data/827054/000082705426000009/mchp-20251231.htm\"\n },\n {\n \"label\": \"FY2025 10-K annual report\",\n \"url\": \"https://www.sec.gov/Archives/edgar/data/827054/000082705425000077/mchp-20250331.htm\"\n },\n {\n \"label\": \"Feb-2026 convertible notes 8-K / indenture\",\n \"url\": \"https://www.sec.gov/Archives/edgar/data/827054/000119312526046713/d18435d8k.htm\"\n },\n {\n \"label\": \"CEO Sanghi Form 4 (Apr-23-2026 sale)\",\n \"url\": \"https://www.sec.gov/Archives/edgar/data/827054/000118192826000018/xslF345X06/wk-form4_1777322521.xml\"\n },\n {\n \"label\": \"KeyBanc analyst raise, May-11-2026\",\n \"url\": \"https://finance.yahoo.com/markets/stocks/articles/keybanc-raises-price-target-microchip-143805426.html\"\n },\n {\n \"label\": \"Everspin MRAM partnership announcement Apr-8-2026\",\n \"url\": \"https://finance.yahoo.com/markets/stocks/articles/why-everspin-technologies-mram-expanding-094125113.html\"\n }\n ],\n \"unfetched_signals\": [\n \"13f_deltas\",\n \"politician_trades\",\n \"sentiment_score\"\n ]\n }\n}\n\nOutput ONLY the decision JSON described in the system prompt. Do NOT\ninclude ... reasoning blocks — they eat the output token\nbudget and produce truncated, unparseable decisions.", "completions": [ { "ts": "2026-05-14T22:36:22.583Z", "raw_content": "The dossier is for MCHP (Microchip Technology).\nMarket cap: ~$52B -> Core risk class.\nVerdict: range_bound_or_income.\nStructure hints: cc, strangle.\n\nLet's score it based on the rubric.\nA. Smart-Money Cluster (max 25):\n- Insider purchases: 0.\n- Insider selling: $96M (CEO Sanghi). Penalty: -10 pts.\n- 13F: pending.\n- Score: 0 (or -10, but min 0). Let's give 0.\n\nB. Options Flow / UOA (max 10):\n- Whale call blocks OTM: none mentioned. Deep ITM $55 call block is a synthetic/LEAP, not OTM directional.\n- IV skew: ATM IV ~50.8%. Not specifically bullish skew mentioned.\n- Net dollar bias: not >30% sustained.\n- Score: 0.\n\nC. Catalyst (max 25):\n- Earnings within 90 days? Next earnings: 2026-08-06. Current date is roughly mid-May 2026 based on dossier (Q4 FY2026 reported May 7). So ~76 days away. But last 4 quarters' EPS surprise > 0%? Yes, 4 consecutive beats. 10 pts.\n- Guidance raise in last 90 days? Yes. +5 pts.\n- Quantifiable sector tailwind? \"Broad semiconductor recovery... Morgan Stanley raised sector price targets\". 5 pts.\n- Cap at 25. Score: 20.\n\nD. Mispricing (max 15):\n- Forward P/E 23.7 vs sector 22. Not below. 0 pts.\n- EV/EBITDA 46.5 vs sector 33. Not below. 0 pts.\n- FCF yield 2.1%. Not ≥7%. 0 pts.\n- SOTP gap null.\n- Score: 0.\n\nE. Quality (max 15):\n- ROIC 3.4%. Not ≥15%. 0 pts.\n- Gross margin expanding ≥3pp YoY? +4.9pp YoY. +5 pts.\n- Net debt / EBITDA 5x. Not ≤2x. 0 pts.\n- Score: 5.\n\nF. Momentum/Technical (max 10):\n- Above 50DMA: yes. +3 pts.\n- Above 200DMA: null.\n- 12-1 month return positive & beating sector? +8% vs sector. +4 pts.\n- RSI 14 in 40-65? 67.2. Close, but >65. 0 pts.\n- MACD bullish cross: false.\n- Score: 7.\n\nTotal Score: 0 + 0 + 20 + 0 + 5 + 7 = 32.\n\nAnti-signal gates:\n- \"dilution\" and \"concentration\" present. Convertible overhang >10%? Dossier says \"$3.9B potential share issuance\" vs $52B market cap (~7.5% float). Might not strictly trigger >10%, but it's a risk. Customer concentration >30%? Arrow Electronics is a major distributor, but not explicitly stated as >30% of revenue. I will note the anti-signal gates.\n- Regardless, score is 32.\n\nRisk Class: Core (> $5B).\nThresholds: < 50 -> Skip.\nReason: Score is 32. The stock is trading at a premium to peers (EV/EBITDA 46x vs 33x), lacks insider buying (CEO sold $96M), and has elevated dilution risk from convertibles. While the recovery trajectory is real, the valuation and lack of asymmetric catalysts make it unsuitable for publication. The dossier itself flags dilution and concentration as anti-signals.\n\nI will output the skip JSON.\nCheck structure:\n{\n \"skip\": true,\n \"score\": 32,\n \"score_breakdown\": {\n \"smart_money\": 0,\n \"options_flow\": 0,\n \"catalyst\": 20,\n \"mispricing\": 0,\n \"quality\": 5,\n \"technical\": 7\n },\n \"reason\": \"MCHP trades at a significant premium to peers (EV/EBITDA 46x vs 33x) with no insider buying and material convertible dilution overhang. The recovery thesis is priced in, and the dossier flags dilution/concentration as anti-signals, failing the high bar for publication.\"\n}\nWait, let's verify the scoring rubric carefully.\nA: 0\nB: 0\nC: 20 (10 for earnings surprise pattern + 5 for guidance raise + 5 for sector tailwind)\nD: 0\nE: 5 (gross margin)\nF: 7 (above 50DMA +3, 12-1 momentum +4)\nTotal: 32.\nMatches thresholds: <50 Skip.\nAll good.\nOutput matches exactly.\nOne minor thing: The prompt says \"Cap at 25 even if components add to more.\" for catalyst. I gave 20. That's fine.\nI will produce the JSON. \nCheck anti-signal gate: \"dilution\" and \"concentration\" are present. The prompt says \"If scoring_inputs has anti_signals_present non-empty, treat each entry as a gate; skip unless you can articulate WHY it doesn't apply to this case.\" I will mention dilution/concentration in the reason.\nReady. \nOutput matches requested format.\nProceeds. \nSelf-Correction/Verification during thought:\nCould I argue for a strangle given range_bound_or_income verdict? The score is 32, well below 60. The rubric says \"< 50 Skip\" for Core. \"If scoring_inputs has anti_signals_present non-empty, treat each entry as a gate; skip unless you can articulate WHY it doesn't apply to this case.\" I will just skip. The prompt emphasizes \"OPTION B (skip) IS THE EXPECTED DEFAULT.\"\nI will output the skip JSON.\nAll numbers and structure match.\nDone. \nOutput Generation. \n```json\n{\n \"skip\": true,\n \"score\": 32,\n \"score_breakdown\": {\n \"smart_money\": 0,\n \"options_flow\": 0,\n \"catalyst\": 20,\n \"mispricing\": 0,\n \"quality\": 5,\n \"technical\": 7\n },\n \"reason\": \"MCHP trades at a significant premium to peers (EV/EBITDA 46x vs 33x) with zero insider buying and material convertible dilution overhang. The recovery thesis is largely priced in, and the dossier flags dilution and customer concentration as active anti-signals, failing the pipeline's high publication bar.\"\n}\n```\nWait, let's double check the score breakdown format. It matches exactly.\nThe prompt says: \"ALL NUMBERS must be drawn from the dossier or computable from it. Do not invent prices, strikes, premiums.\"\nI'm skipping, so no prices needed.\nEverything looks solid.\nProceeds. \nOutput matches request. \nFinal Check of the prompt: \"ONLY ONE STRUCTURE TYPE... IF YOU SKIP — output exactly: { ... }\"\nI will output exactly that.\nDone. \nProceeds. \n[Output Generation] -> *Self-Correction/Refinement during generation prep*: \nI should ensure the JSON is strictly valid and matches the schema.\nThe schema for skip:\n{\n \"skip\": true,\n \"score\": ,\n \"score_breakdown\": { ... },\n \"reason\": \"...\"\n}\nMatches.\nScore: 32.\nBreakdown: smart_money: 0, options_flow: 0, catalyst: 20, mispricing: 0, quality: 5, technical: 7.\nReason: concise.\nReady. \nOutput matches. \nProceeds. \n[Output Generation] (done)\n\n\n{\n \"skip\": true,\n \"score\": 32,\n \"score_breakdown\": {\n \"smart_money\": 0,\n \"options_flow\": 0,\n \"catalyst\": 20,\n \"mispricing\": 0,\n \"quality\": 5,\n \"technical\": 7\n },\n \"reason\": \"MCHP trades at a significant premium to peers (EV/EBITDA 46x vs 33x) with zero insider buying and material convertible dilution overhang. The recovery thesis is largely priced in, and the dossier flags dilution and customer concentration as active anti-signals, failing the pipeline's high publication bar.\"\n}", "cleaned_content": "{\n \"skip\": true,\n \"score\": 32,\n \"score_breakdown\": {\n \"smart_money\": 0,\n \"options_flow\": 0,\n \"catalyst\": 20,\n \"mispricing\": 0,\n \"quality\": 5,\n \"technical\": 7\n },\n \"reason\": \"MCHP trades at a significant premium to peers (EV/EBITDA 46x vs 33x) with zero insider buying and material convertible dilution overhang. The recovery thesis is largely priced in, and the dossier flags dilution and customer concentration as active anti-signals, failing the pipeline's high publication bar.\"\n}", "tool_calls": null, "finish_reason": "stop" } ], "tool_results": [], "final_message": "{\n \"skip\": true,\n \"score\": 32,\n \"score_breakdown\": {\n \"smart_money\": 0,\n \"options_flow\": 0,\n \"catalyst\": 20,\n \"mispricing\": 0,\n \"quality\": 5,\n \"technical\": 7\n },\n \"reason\": \"MCHP trades at a significant premium to peers (EV/EBITDA 46x vs 33x) with zero insider buying and material convertible dilution overhang. The recovery thesis is largely priced in, and the dossier flags dilution and customer concentration as active anti-signals, failing the pipeline's high publication bar.\"\n}", "tool_calls_total": 0, "walltime_ms": 31661, "stop_reason": "stop", "completed_at": "2026-05-14T22:36:22.583Z" }